People: PerkinElmer Inc (PKI)
10 Dec 2013
Dr. Daniel R. Marshak, Ph.D., is Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics of PerkinElmer Inc. Dr. Marshak was appointed Company's Senior Vice President in April 2008, having joined the Company as Company's Chief Scientific Officer in May 2006. In addition to these responsibilities, in May 2010, Dr. Marshak was appointed President of Company's Emerging Diagnostics business. Dr. Marshak previously held the position of President, Greater China for the Company. Prior to joining the Company, Dr. Marshak was with Cambrex Corporation since 2000, most recently as Vice President and Chief Technology Officer for Biotechnology. Dr. Marshak also previously held the positions of Senior Vice President and Chief Scientific Officer for Osiris Therapeutics, Inc. and Senior Staff Investigator, Cold Spring Harbor Laboratory. Dr. Marshak received his Bachelor of Arts degree in biochemistry and molecular biology from Harvard University, and his doctorate in biochemistry and cell biology from The Rockefeller University. Dr. Marshak performed postdoctoral research in pharmacology at Vanderbilt University and the National Institute of Health. Dr. Marshak is the author of more than 100 scientific publications and an inventor on six United States patents.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|